Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06880094

Study of Congenital Orofacial Clefts by Implementing Optical Genome Mapping

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Orofacial clefts, the most common congenital craniofacial malformations, have a complex etiology involving an interaction between genetic and environmental factors. Chromosomal abnormalities, including structural variations, represent a major cause of human pathology. Recently, technological developments and the introduction of next-generation sequencing (NGS) technologies have revolutionized the field of medical genetics. Optical genome mapping (OGM) is an innovative, high-resolution "long read" technique that enables the identification of all classes of chromosomal variation, consisting in the direct visualization of long, labeled DNA molecules throughout the genome. This technology is gradually becoming an essential tool for studying onco-hematology and constitutional genetic pathologies The purpose of this study is to search for structural chromosomal variants (SV) or copy number variants (CNV) not identifiable either by cytogenetic methods nor by "short read" NGS "short read, in individuals with oral-facial clefts with no genetic diagnosis.

Conditions

Interventions

TypeNameDescription
GENETICblood withdrawalblood withdrawal for genetic testing

Timeline

Start date
2025-02-18
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2025-03-17
Last updated
2026-01-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06880094. Inclusion in this directory is not an endorsement.

Study of Congenital Orofacial Clefts by Implementing Optical Genome Mapping (NCT06880094) · Clinical Trials Directory